April 26, 2018

Introducing Featured Open Lectures

This is a new initiative from the Society to highlight our online educational platform EAS ACADEMY. Every other month we select one interesting lecture from a recent course or Congress and make it available for free, to members and non-members.


Open Lecture May-June 2018

Lowering LDL in Cardiovascular Disease – LDL as the Primary Causative factor and Treatment Target

This presentation was given as a plenary lecture at the EAS Congress in Prague, 2017, by Professor Chris Packard at the University of Glasgow, UK. In this lecture Professor Packard reviews the overwhelming evidence that LDL is the key causative factor for atherosclerosis – evidence obtained from experimental studies, epidemiology, genetics, pathophysiology and from clinical trials. He also takes this knowledge into the understanding of the mechanisms of the drugs shown to reduce CVD by reduction of LDL-Cholesterol.

Free access to the lecture will be open until June 30.

To the Featured Open Lecture >>


In SHORT TRACKS we collect 2-4 recent lectures from EAS congresses or courses, putting them together to provide up-to-date perspectives on a given current topic. This month’s SHORT TRACK topic is Triglyceride-rich Lipoproteins and their Remnants in Cardiovascular Disease. Under this headline we have gathered the three presentations described below.

To the SHORT TRACK Triglyceride-rich Lipoproteins and their Remnants in Cardiovascular Disease >> 

These presentations are open for EAS members only. Register as an EAS Individual member, and the whole ACADEMY is open for you.

How to register as an EAS member >>

Demystifying the management of hypertriglyceridemia

A presentation by Professor Anne Tybjaerg-Hansen from Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. In this presentation we get basics on triglycerides and CVD risk and are also taken through the underlying genetic studies, primarily based on the data from Copenhagen. Furthermore Professor Tybjaerg-Hansen tells us about the new treatment targets that are being developed based on Mendelian randomization studies.

To the presentation >>

Why TG-Rich Lipoproteins/non-HDL cholesterol matter when assessing CVD RISK? – Atherogenic dyslipidaemia

This presentation is made by Professor Alberto Zambon, University of Padua, Italy. Professor Zambon approaches the subject from a practical point of view. What should we measure to capture the CVD risk beyond LDL and how can we interpret the analyses of different lipoprotein fraction in practice.

To the presentation >>

How to treat diabetic dyslipidaemia

Professor Gerald F Watts from Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital, School of Medicine, University of Western Australia, Australia talks about how to treat the residual risk in diabetic patients. His approach is practical and patient oriented and should be of major interest for all physicians seeing this group of patients.

To the presentation >>

Featured events

The following highlighted events are only open for EAS members. Register as an EAS Individual member, and the whole ACADEMY is open for you.

How to register as EAS member >>

EAS Advanced Course on Atherothrombosis, 2017

The advanced course on Atherothrombosis that was held in Vienna in November 2017 provided a comprehensive overview of the basic principles of atherothrombosis as well the vascular alterations leading to it. Both clinical and basic science experts gave stimulating presentations on topics ranging from vascular inflammation to plaque vulnerability and clinical aspects of atherothrombosis. The contribution of the vessel wall and plaque composition as well as the role of all major vascular cells and humoral factors in atherothrombosis were discussed. Finally, novel concepts such as immunothrombosis, the role of the gut microbiome, as well as systemsbiology approaches in cardiovascular medicine were presented.

 To the event >>

EAS Advanced Course in Precision Medicine in Atherosclerosis, 2017

This course takes precision medicine into the field of atherosclerosis. The starting point is the question whether precision medicine is an unmet need or just a fashion? The question is discussed from several perspectives. How can genetics help to make treatment more specific? What does new biomarkers add to improve diagnosis? Will new imaging techniques result in new possibilities to identify disease. Can new methods help to personalize therapy and can we direct therapy with precision to more specific targets? In this course these subjects are discussed by a number of researchers in the front line of this scientific area.

To the event >>

Containing topical and educational presentations, recorded at EAS Congress and Advanced Courses, and delivered by some of the leading authorities in the field, EAS Academy is the go-to resource for state-of the art information on atherosclerosis research.

Find out more

About EAS

EAS Membership

EAS Congress

EAS Educational Initiatives

EAS Publications

European Lipoprotein Club (ELC)

EAS-FH Studies Collaboration (FHSC)

Visit: eas-society.org

About this email

You have received this email because you are currently subscribed to receive general correspondence from EAS.


European Atherosclerosis Society
Mässans Gata 18
Box 5243
SE-402 24, Gothenburg SWEDEN

Organisation number: 802418-0427

This email was sent to '@@email@@' from European Atherosclerosis Society.
If you wish to stop receiving email from us, you can simply remove yourself by visiting: @@unsubscribe_url@@


European Atherosclerosis Society © 2018